The Latest Treatments for Uterine Cancer and What’s in the Pipeline

Uterine cancer molecular categories now drive many treatment options. Join Dr. Gottfried Konecny, gynecologic medical oncologist and professor at UCLA Health, as he explains new treatments that span across molecular categories, with a particular emphasis on the No Specific Mutational Profile (NSMP). Of the four molecular categories for uterine cancer, over 50% of endometrial cancers are classified into the NSMP category. This is a category that includes hormone positive, HER2 negative, pMMR, MS-stable, tumor mutational burden low, p53 wildtype, and other cancer mutations that are not covered in the other three mutational categories.  As a physician-scientist, Dr. Konecny translates research into novel treatment approaches for the NSMP category and beyond. ▶️ Presenter: Dr. Gottfried Konecny, Gynecologic Medical Oncologist and Professor at UCLA Health ▶️ Access our FREE services about uterine or endometrial cancer at: sharecancersupport.org/uterine-cancer/ ▶️ Subscribe to our newsletter: sharecancersupport.org/newsletter/ ▶️ Learn from our endometrial/uterine cancer experts in our playlist: https://bit.ly/4cc05sm ▶️ Follow us on social media: Instagram: instagram.com/sharecancersupport/ Facebook: facebook.com/SHARECancerSupport LinkedIn: linkedin.com/company/share-cancer-support/ #sharecancersupport #uterinecancer #uterinecancertreatment #cancertreatments